Abstract
Purpose. This study was done to determine the E-ring hydrolysis and lactonization mechanism of a water-soluble 20-phosphoryloxymethyl (POM) prodrug of camptothecin (P-CPT). Specifically, the role of the phosphate group in facilitating E-ring hydrolysis was examined.
Methods. Resolution between the lactone and carboxylate forms of P-CPT and camptothecin (CPT) was achieved with a RPHPLC assay using UV-visible detection. E-ring P-CPT hydrolysis and lactonization kinetics were followed using 20 mM acetate or phosphate buffer (μ = 0.15 NaCl) over the pH range of 4 to 8 at 25.0°C. A kinetic solvent isotope effect (KSIE) study was used to further probe the mechanism of E-ring hydrolysis.
Results. The hydrolysis and lactonization reactions followed pseudo-first-order kinetics in the approach to equilibrium. The equilibrium ratio of the open and closed forms of P-CPT was dependent on pH, with the closed form dominant at low pH and the open form dominant at high pH. Buffer concentration changes had little to no effect on the rate of P-CPT E-ring hydrolysis. The KSIE study provided an overall isotope effect of 2.47 and a proton inventory KSIE consistent with an intramolecular general base catalysis.
Conclusions. P-CPT has a pH-dependent equilibrium between the lactone and carboxylate forms similar but not identical to that of CPT. The results suggest a hydrolysis reaction mechanism that involves a single site hydrogen exchange facilitated intramolecularly by the dianionic phosphate moiety of P-CPT via either general base catalysis of the lactone ring attack by water or breakdown of the tetrahedral intermediate.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
J. Fassberg and V. J. Stella. A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues. J. Pharm. Sci. 81:676–684 (1992).
M. E. Wall, M. C. Wani, C. E. Cook, K. H. Palmer, A. T. McPhail, and G. A. Sim. Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata. J. Am. Chem. Soc. 88:3888–3890 (1966).
M. C. Wani and M. E. Wall. Plant antitumor agents. II. The structure of two new alkaloids from Camptotheca acuminata. J. Org. Chem. 34:1364–1367 (1969).
J. A. Adamovics and C. R. Hutchinson. Prodrug analogues of the antitumor alkaloid camptothecin. J. Med. Chem. 22:310–314 (1979).
M. C. Wani, P. E. Ronman, J. T. Lindley, and M. E. Wall. Plant antitumor agents. 18. Synthesis and biological activity of camptothecin analogues. J. Med. Chem. 23:554–560 (1980).
M. C. Wani, A. W. Nicholas, and M. E. Wall. Plant antitumor agents. 23. Synthesis and antileukemic activity of camptothecin analogues. J. Med. Chem. 29:2358–2363 (1986).
M. C. Wani, A. W. Nicholas, G. Manikumar, and M. E. Wall. Plant antitumor agents. 25. Total synthesis and antileukemic activity of ring A substituted camptothecin analogues. Structure–activity correlations. J. Med. Chem. 30:1774–1779 (1987).
W. Eng, L. Faucette, R. K. Johnson, and R. Sternglanz. Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin. Mol. Pharmacol. 34:755–760 (1988).
C. Jaxel, K. W. Kohn, M. C. Wani, M. E. Wall, and Y. Pommier. Structure–activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: Evidence for a specific receptor site and a relation to antitumor activity. Cancer Res. 49:1465–1469 (1989).
Y. Hsiang, L. F. Liu, M. E. Wall, M. C. Wani, A. W. Nicholas, G. Manikumar, S. Kirschenbaum, R. Silber, and M. Potmesil. DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues. Cancer Res. 49:4385–4389 (1989).
R. P. Hertzberg, M. J. Caranfa, and S. M. Hecht. On the mechanism of topoisomerase I inhibition by camptothecin: Evidence for binding to an enzyme–DNA complex. Biochemistry 28:4629–4638 (1989).
Y. Hsiang, M. G. Lihou, and L. F. Liu. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res. 49:5077–5082 (1989).
M. Bjornsti, P. Benedetti, G. A. Viglianti, and J. C. Wang. Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: Restoration of sensitivity of the cells to the antitumor drug camptothecin. Cancer Res. 49:6318–6323 (1989).
M. Gupta, A. Fujimori, and Y. Pommier. Eurkaryotic DNA topoisomerase I. Biochim. Biophys. Acta 1262:1–14 (1995).
J. C. Wang. DNA topoisomerases. Annu. Rev. Biochem. 65:635–692 (1996).
C. Jaxel, G. Capranico, D. Kerrigan, K. W. Kohn, and Y. Pommier. Effect of local DNA sequence on topoisomerase I cleavage in the presence or absence of camptothecin. J. Biol. Chem. 266:20418–20423 (1991).
Y. Pommier, G. Kohlhagen, K. W. Kohn, F. Leteurtre, M. C. Wani, and M. E. Wall. Interaction of an alkylating camptothecin derivative with a DNA base at topoisomerase I-DNA cleavage sites. Proc. Natl. Acad. Sci. USA 92:8861–8865 (1995).
J. A. Gottlieb and J. K. Luce. Treatment of malignant melanoma with camptothecin (NSC-100880). Cancer Chemother. Rep. 56:103–105 (1972).
F. M. Muggia, P. J. Creaven, H. H. Hansen, M. H. Cohen, and O. S. Selawry. Phase 1 clinical trial of weekly and daily treatment with camptothecin (NSC-100880): Correlation with preclinical studies. Cancer Chemother. Rep. 56:515–521 (1972).
P. J. Creaven, L. M. Allen, and F. M. Muggia. Plasma camptothecin (NSC-100880) levels during a 5-day course of treatment: Relation to dose and toxicity. Cancer Chemother. Rep. 56:573–578 (1972).
M. E. Wall and M. C. Wani. Antineoplastic agents from plants. Annu. Rev. Pharmacol. Toxicol. 17:117–132 (1977).
R. P. Hertzberg, M. J. Caranfa, K. G. Holden, D. R. Jakas, G. Gallagher, M. R. Mattern, S. M. Mong, J. O. Bartus, R. K. Johnson, and W. D. Kingsbury. Modification of hydroxy lactone ring of camptothecin; inhibition of topoisomerase I and biological activity. J. Med. Chem. 32:715–720 (1989).
M. Safadi, R. Olizai, and V. J. Stella. Phosphoryloxymethyl carbamates and carbonates—Novel water-soluble prodrugs for amines and hindered alcohols. Pharm. Res. 10:1350–1355 (1993).
J. P. Krise, J. Zygmunt, G. I. Georg, and V. J. Stella. Novel prodrug approach for tertiary amines: Synthesis and preliminary evaluation of N-phosphonooxymethyl prodrugs. J. Med. Chem. 42:3094–3100 (1999).
J. P. Krise, S. Narisawa, and V. J. Stella. A novel prodrug approach for tertiary amines. 2. Physiochemical and in vitro enzymatic evaluation of selected N-phosphonooxymethyl prodrugs. J. Pharm. Sci. 88:922–927 (1999).
J. P. Krise, S. Narisawa, and V. J. Stella. A novel prodrug approach for tertiary amines. 3. In vivo evaluation of two N-phosphonooxymethyl prodrugs in rats and dogs. J. Pharm. Sci. 88:928–932 (1999).
M. E. Wall. Plant antitumor agents. 5. Alkaloids with antitumor activity. In K. Mothes, K. Schrieber and H. R. Schulte (eds.), International Symposium on Biochemistry and Physiology of the Alkaloids, Academie-Verlag, Berlin, 1969, pp. 77–87.
A. W. Nicholas, M. C. Wani, G. Manikumar, M. E. Wall, K. W. Kohn, and Y. Pommier. Plant antitumor agents. 29. Synthesis and biological activity of ring D and ring E modified analogues of camptothecin. J. Med. Chem. 33:972–978 (1990).
V. J. Stella, J. J. Zygmunt, I. G. Georg and M. S. Safadi. Water soluble prodrugs of hindered alcohols. United States Patent 6,204,257, March 20, 2001.
K. B. Schowen and R. L. Schowen. Solvent isotope effects on enzyme systems. Methods Enzymol. 87C:551–606 (1982).
M. J. Kaufman. Rate and equilibrium constants for acid-catalyzed lactone hydrolysis of HMG-CoA reductase inhibitors. Int. J. Pharm. 66:97–106 (1990).
J. Emsley and D. Hall. Reaction mechanisms. In J. Emsley (ed.), The Chemistry of Phosphorus: Environmental, Organic, Inorganic, Biochemical, and Spectroscopic Aspects, John Wiley & Sons, New York, 1976, pp. 232.
W. D. Kumler and J. J. Eiler. The acid strength of mono and diesters of phosphoric acid: The n-alkyl esters from methyl to butyl, the esters of biological importance and the natural guanidine phosphoric acids. J. Am. Chem. Soc. 65:2355(1943).
W. P. Jencks. and J. Regenstein. Physical and Chemical Data. In G. D. Fasman (ed.), Handbook of Biochemistry and Molecular Biology, CRC Press, Cleveland, 1976, pp. 310–342.
Y. Pocker and E. Green. Hydrolysis of D-glucono-δ-lactone. I. General acid-base catalysis, solvent deuterium isotope effects, and transition state characterization. J. Am. Chem. Soc. 95:113–119 (1973).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hanson, B.A., Schowen, R.L. & Stella, V.J. A Mechanistic and Kinetic Study of the E-Ring Hydrolysis and Lactonization of a Novel Phosphoryloxymethyl Prodrug of Camptothecin. Pharm Res 20, 1031–1038 (2003). https://doi.org/10.1023/A:1024410322870
Issue Date:
DOI: https://doi.org/10.1023/A:1024410322870